What is the appropriate NSAID dosage for primary dysmenorrhea?

NSAID Dosage for Primary Dysmenorrhea

For primary dysmenorrhea, use ibuprofen 400-800 mg every 6-8 hours with food, naproxen sodium 440-550 mg initially followed by 250 mg every 6-12 hours (maximum 1250 mg daily), or mefenamic acid 500 mg three times daily for 5-7 days starting at pain onset.

Algorithmic Approach to NSAID Selection and Dosing

First-Line NSAID Options

The evidence supports several effective NSAID regimens, with choice depending on desired dosing frequency and duration of action:

Ibuprofen (most commonly used):

• Initial dose: 400-800 mg
• Maintenance: 400-800 mg every 6-8 hours with food
• Maximum: 2400 mg/day
• Duration: First 24 hours post-symptom onset 1, 2

Naproxen sodium (longer-acting, less frequent dosing):

• Loading dose: 440-550 mg (or 500 mg) at first sign of pain
• Maintenance: 250 mg every 6-12 hours as needed
• Maximum: 1250 mg/day
• Duration: Throughout menstrual distress period 3, 4

Mefenamic acid (evidence-based for dysmenorrhea):

• Dose: 500 mg three times daily
• Duration: 5 days
• Demonstrated significant bleeding cessation within 7 days in contraceptive-related bleeding studies 5

Alternative NSAIDs with Evidence

Diclofenac potassium:

• Dose: 50 mg three times daily (150 mg total daily)
• Provides consistent 24-hour pain relief
• Highly effective for severe dysmenorrhea 6

Piroxicam (once-daily option):

• Loading: 40 mg on days 1-2
• Maintenance: 20 mg daily on days 3-5
• Single daily dosing may improve adherence 7

Clinical Implementation Strategy

Timing of Initiation

Start NSAIDs at the first sign of menstrual pain or bleeding—do not wait for pain to become severe. Earlier initiation provides superior pain control by preventing prostaglandin accumulation 3, 6.

Treatment Duration

• Short-term use: 5-7 days is the standard recommendation across guidelines 5
• This duration balances efficacy with minimizing NSAID-related adverse effects
• Most women require treatment only during the first 1-3 days of menses when pain is most severe

Key Advantages by Agent

Choose ibuprofen when:

• Patient prefers familiar medication
• Cost is a primary concern (generic availability)
• Flexible dosing needed (can titrate 400-800 mg)

Choose naproxen sodium when:

• Longer duration of action desired (less frequent dosing)
• Patient has difficulty with medication adherence
• Proven superior efficacy over acetaminophen for 12+ hours 3

Choose mefenamic acid when:

• Patient has failed ibuprofen/naproxen
• Concurrent hormonal contraceptive-related bleeding issues 5

Critical Prescribing Considerations

Contraindications to Screen For

Before prescribing any NSAID, verify absence of:

• Active peptic ulcer disease or GI bleeding history
• Aspirin/NSAID-induced asthma (especially with nasal polyps)
• Severe renal impairment (creatinine clearance <30 mL/min)
• Active cardiovascular disease or recent MI
• Third trimester pregnancy 2, 8

Gastrointestinal Protection Strategy

• Age <65 years, no GI risk factors: NSAID alone is appropriate 9
• Age >65 years OR history of GI bleeding: Add proton pump inhibitor or consider COX-2 selective agent 8, 9
• Concurrent aspirin use: NSAID alone is inappropriate; add PPI 9

Common Pitfalls to Avoid

1. Delaying treatment until pain is severe: NSAIDs work by preventing prostaglandin synthesis—they are less effective once pain is established
2. Underdosing: Using 200-400 mg ibuprofen when 600-800 mg is needed for adequate analgesia
3. Inadequate duration: Stopping after 1-2 days when 3-5 days may be needed
4. Combining multiple NSAIDs: Never use two NSAIDs simultaneously (increases toxicity without improving efficacy)
5. Ignoring cardiovascular risk: All NSAIDs can increase blood pressure by ~5 mmHg and worsen heart failure 8

Evidence Quality Notes

The most recent high-quality evidence comes from a 2026 crossover trial demonstrating pelubiprofen 45 mg efficacy 10, though this agent has limited availability. The 2019 naproxen sodium vs. acetaminophen trial provides Level I evidence for naproxen's superiority with significant pain relief maintained for 12 hours 3. The 2014 diclofenac study offers compelling evidence for 24-hour efficacy with the recommended daily dose 6.

The 2025 ACOG guideline on primary dysmenorrhea 11 emphasizes that treatment should not be delayed pending definitive diagnosis and can be initiated without pelvic examination, supporting immediate NSAID therapy at symptom onset.